Ketamine for Methamphetamine Use Disorder

Running, not enrolling · Phase 2

Conditions studied: Substance Use Disorders, Substance Use, Methamphetamine Abuse

In brief

This study aims to determine whether treatment response with IV ketamine is superior to treatment response with IV midazolam in adults with moderate to severe MUD. The study design is a 12-week randomized, double-blind, controlled trial comparing intravenous (IV) ketamine against IV midazolam, delivered over six weeks in 120 adults with moderate to severe methamphetamine use disorder (MUD).

Key facts

Study ID
NCT06496750
Run by
University of Texas Southwestern Medical Center
People needed
120
Starts
2024-09-11
Expected to finish
2026-10-01
Last updated by the study team
2026-08-04

Who can join

Age: 18 and older, up to 65. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

You may not qualify if…

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.